论文信息 - Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study - 字舞流文

Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study

P. Aló | G. Perrone | G. Fadda | G. d’Amati | L. Costarelli | Ilaria Girolami | A. Eccher | Maurizio Martini | S. Taccogna | B. Cerbelli | M. Benevolo | F. Stella | M. G. Pignataro | R. Scialpi | Teresa Lucante